|

Twist Bioscience Corp (NASDAQ: TWST) daily investment opportunity

Twist Bioscience (NASDAQ: TWST) is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries. In this article, we will be explored the Elliott Wave structure based on the daily cycle .

From the low on 5/2/2023, TWST rallied an impressive 246% until late December. This upward move unfolded in three swings. Wave I ended at $27.36, wave II at $14.42, and wave III recently ended at $39.74. According to the Elliott Wave Theory, the proposed wave IV pullback is expected to unfold in 3, 7, or 11 swings above the $14.42 low. Consequently, after ending current pullback, the stock is expected to resume its rally in wave V.

TWST daily chart 1.25.2024

Chart

Examining the above chart, we observe a projected correction in wave IV. This correction appears within a three-wave Zigzag structure ((A)) ((B)) ((C)). It’s expected to reach equal legs at $30.33 – $25.59, then ascend. The blue box represents a high frequency area where market cycles are likely to end and pivot. Consequently, TWST is expected to attract buyers and initiate the next upward leg within wave V.

In conclusion, TWST presents a potential investment opportunity. This opportunity is within the daily correction against the low of October 2023. Consequently, it could reach new highs, ideally later this year

Author

Elliott Wave Forecast Team

Elliott Wave Forecast Team

ElliottWave-Forecast.com

More from Elliott Wave Forecast Team
Share:

Editor's Picks

EUR/USD tests 1.1800 barrier above 50-day EMA

EUR/USD gains ground after three days of losses, trading around 1.1790 during the Asian hours on Thursday. The 14-day Relative Strength Index momentum indicator at 47 (neutral) reflects easing momentum. The RSI below 50 keeps momentum balanced and could limit follow-through.

GBP/USD struggles near four-week low vs. USD, below 1.3500 amid BoE rate cut bets

The GBP/USD pair is seen consolidating its weekly losses registered over the past three days and oscillating in a narrow range near a four-week trough, touched during the Asians session on Thursday. Spot prices currently trade just below the 1.3500 psychological mark and seem vulnerable to slide further.

Gold consolidates below $5,000 amid geopolitical risk, hawkish FOMC Minutes

Gold extends its sideways consolidative price move through the Asian session on Thursday and remains below the $5,000 psychological mark as traders seem hesitant amid mixed cues. The US Dollar preserves its strong gains to over a one-week high in the wake of somewhat hawkish Minutes of the US Federal Reserve’s January monetary policy meeting. 

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments. The technical outlook suggests further gains if INJ breaks above key resistance.

Mixed UK inflation data no gamechanger for the Bank of England

Food inflation plunged in January, but service sector price pressure is proving stickier. We continue to expect Bank of England rate cuts in March and June. The latest UK inflation read is a mixed bag for the Bank of England, but we doubt it drastically changes the odds of a March rate cut.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.